|
RAB6C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.645900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.104600E-03 |
| Normal-vs-Stage2 |
6.276800E-01 |
| Normal-vs-Stage3 |
4.908800E-01 |
| Normal-vs-Stage4 |
8.309000E-01 |
| Stage1-vs-Stage2 |
3.683600E-01 |
| Stage1-vs-Stage3 |
1.007690E-02 |
| Stage1-vs-Stage4 |
4.878200E-01 |
| Stage2-vs-Stage3 |
3.475400E-01 |
| Stage2-vs-Stage4 |
9.167000E-01 |
| Stage3-vs-Stage4 |
5.314800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.736400E-02 |
| Normal-vs-AfricanAmerican |
2.329400E-01 |
| Normal-vs-Asian |
4.082000E-01 |
| Caucasian-vs-AfricanAmerican |
2.936200E-01 |
| Caucasian-vs-Asian |
7.566200E-01 |
| AfricanAmerican-vs-Asian |
9.494000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.322130E-02 |
| Normal-vs-Female |
5.607000E-01 |
| Male-vs-Female |
2.547900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.130400E-01 |
| Normal-vs-Extreme_Weight |
3.339300E-03 |
| Normal-vs-Obese |
1.959650E-01 |
| Normal-vs-Extreme_Obese |
9.414400E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.603400E-01 |
| Normal_Weight-vs-Obese |
9.943600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.285800E-01 |
| Extreme_Weight-vs-Obese |
1.627390E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.765400E-01 |
| Obese-vs-Extreme_Obese |
5.864400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.461200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.358000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.957770E-03 |
| Normal-vs-Age(81-100Yrs) |
2.698000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.486600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.316420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.947200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.382500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.281000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.265000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.424100E-03 |
| Normal-VS-Type2 PRCC |
1.104650E-01 |
| Normal-VS-KIRP CIMP |
5.952000E-01 |
| Normal-VS-Unclassified PRCC |
8.891400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.318600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.731570E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.920000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.226500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.575800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.148000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.339140E-03 |
| Normal-vs-N1 |
4.707400E-01 |
| Normal-vs-N2 |
5.417600E-02 |
| N0-vs-N1 |
1.499710E-02 |
| N0-vs-N2 |
4.551800E-01 |
| N1-vs-N2 |
1.556170E-01 |
|
|
